<?xml version="1.0" encoding="UTF-8"?>
<p id="p0080">As with other human coronaviruses, the diagnostic gold standard for SARS-CoV-2 is via RT-PCR, commonly utilising genes encoding the internal RNA-dependent RNA polymerase and surface spike glycoprotein.
 <xref rid="bib61" ref-type="bibr">61</xref>, 
 <xref rid="bib62" ref-type="bibr">62</xref>, 
 <xref rid="bib63" ref-type="bibr">63</xref> Higher viral loads have been documented in the lower respiratory tract,
 <xref rid="bib64" ref-type="bibr">
  <sup>64</sup>
 </xref> consistent with what has been observed for SARS-CoV and Middle East respiratory syndrome (MERS).
 <xref rid="bib65" ref-type="bibr">
  <sup>65</sup>
 </xref> In some settings, where there is a strong clinical suspicion of SARS-CoV-2 yet a negative result on nasopharyngeal or throat swab, lower respiratory tract sampling is recommended;
 <xref rid="bib66" ref-type="bibr">
  <sup>66</sup>
 </xref> however, this should be reserved for the most unwell children in light of the risks associated with obtaining lower respiratory tract samples.
</p>
